Learning Objectives:
•1. Present a clinical vignette demonstrating potential issues with vasopressin usage
•2. Establish dangers of vasopressin when used as high-dose bolus
•3. Demonstrate clinical safety of norepinephrine for peripheral use as pressor
•4. Discuss feasibility of implementing addition of norepinephrine to our practice
.
Session date:
12/02/2020 - 7:00am to 8:00am CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Joshua Junge, MD